Search Legislation

The Medicines (Products for Human Use — Fees) Regulations 1995

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). UK Statutory Instruments are not carried in their revised form on this site.

Regulation 17 (1)

SCHEDULE 4TIME FOR PAYMENT OF CAPITAL FEES — APPLICATIONS MADE BY SMALL COMPANIES

1.  In this Schedule a reference to an application is to an application made by or on behalf of a small company.

2.  In connection with a major application for a marketing authorization for which the fee payable is that specified in entry 1(c) of the Table in paragraph 1 of Part II of Schedule 1, the fee payable under regulation 4(a) shall, if the applicant so requests in writing, be payable as to 25% at the time of the application and as to 75% within 30 days following written notice from the licensing authority that the application has been determined.

3.  In connection with a complex application for a marketing authorization, the fee payable under regulation 4(a) shall, if the applicant so requests in writing, be payable as to 50% at the time of the application and as to 50% within 30 days following written notice from the licensing authority that the application has been determined.

4.  In connection with an application to which paragraph 4 of Part II of Schedule 1 applies, the fee payable under regulation 4(a) shall, if the applicant so requests in writing, be payable—

(a)as to 50% of the aggregate payable in accordance with that paragraph at the time of the application; and

(b)as to 50% of that aggregate within 30 days following written notice from the licensing authority that the application has been determined.

5.  In connection with an application for a manufacturer’s licence or a wholesale dealer’s licence, the fee payable under regulation 4(a) shall, if the applicant so requests in writing, be payable as to 50% at the time of the application and as to 50% 12 months after that time.

6.  In connection with an application for a marketing authorization, manufacturer’s licence or wholesale dealer’s licence, the fee payable in respect of an inspection at any site other than one named as a possible site for manufacture of a medicinal product by three or more applicants shall, if the applicant so requests in writing, be payable as to 50% within the period of 14 days referred to in regulation 16(2) and as to 50% 12 months after that date.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once